SF 1098 Minnesota Senate · 2019-2020 Regular Session

Prescription Drug Pricing Transparency Act

Bill status signed all 5 stages cleared
Introduction
Feb 2019
Committee Review
May 2020
Senate Passage
Apr 2020
House Passage
May 2020
Signed into Law
May 2020
Introduced Feb 11, 2019 Signed May 15, 2020
Floor votes · House May 9, 2020

How they voted

This bill passed the Senate by voice vote (no roll call recorded).
Full legislative history

Actions timeline

Total actions
22
Key actions
8
Committee
6
Amendments
1
May 15, 2020
Signed into law
Governor's action Approval 05/12/2020
executive
May 12, 2020
Introduced
Secretary of State, Filed 05/12/2020
lower
May 12, 2020
Signed into law
Governor approval 05/12/2020
executive
May 9, 2020
Lower · Passed
Bill was passed
lower
May 5, 2020
Lower · Passed
Committee report, to adopt
lower
Apr 28, 2020
Committee
Senate file first reading, referred to Ways and Means
lower
Apr 28, 2020
Introduced
Received from Senate
lower
Apr 20, 2020
Upper · Passed
Third reading Passed
upper
Apr 20, 2020
Introduced
Special Order: Amended
upper
Mar 11, 2020
Upper · Passed
Comm report: To pass as amended
upper
Feb 20, 2020
Upper · Passed
Comm report: To pass as amended and re-refer to Finance
upper
Mar 27, 2019
Upper · Passed
Comm report: To pass as amended and re-refer to Judiciary and Public Safety Finance and Policy
upper
Feb 11, 2019
Committee
Referred to Health and Human Services Finance and Policy
upper
Feb 11, 2019
Introduced
Introduction and first reading
upper
1 primary · 33 co-sponsors

Sponsors